| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/30/2002 | US6426196 Alphavirus structural protein expression cassettes |
| 07/30/2002 | US6426188 Antisense modulation of phosphorylase kinase alpha 1 expression |
| 07/30/2002 | US6426042 Methods and kits for improving retroviral-mediated gene transfer utilizing molecules, or mixture thereof, containing retroviral binding domains and target cell binding domains |
| 07/30/2002 | CA2369405A1 Har a polypeptides and nucleic acids, and related methods and uses thereof |
| 07/30/2002 | CA2079777C Oligonucleotide analogs |
| 07/30/2002 | CA2060490C Protection from shock subsequent to injury by double-stranded rnas |
| 07/25/2002 | WO2002058323A2 Method for identifying modulators of bace |
| 07/25/2002 | WO2002057480A2 Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers |
| 07/25/2002 | WO2002057472A1 Selectable marker for genetically engineered cells and tissues |
| 07/25/2002 | WO2002057462A1 Vector for introducing molecules in eukaryotic cells and molecules vectorized by same |
| 07/25/2002 | WO2002057461A2 Regulation of human adam-ts-like zinc metalloprotease |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057457A2 Human proteins 55562 and 21617, and methods of use thereof |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057429A2 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 07/25/2002 | WO2002057424A2 Nucleic acid delivery formulations |
| 07/25/2002 | WO2002057419A2 Protein-protein interactions |
| 07/25/2002 | WO2002057415A2 Method for altering cell fate |
| 07/25/2002 | WO2002057409A2 Antisense modulation of src-2 expression |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002057294A2 Zinc finger proteins for dna binding and gene regulation in plants |
| 07/25/2002 | WO2002057293A2 Modified zinc finger binding proteins |
| 07/25/2002 | WO2002056918A2 Method of enhancing delivery of a therapeutic nucleic acid |
| 07/25/2002 | WO2002056917A1 A recombination virus able to specifically kill tumor associated with eb virus and the constructing method thereof |
| 07/25/2002 | WO2002056891A1 Regulation of glucocorticoid concentration |
| 07/25/2002 | WO2002056828A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 07/25/2002 | WO2002056668A2 Methods to control the host range of retroviral vectors |
| 07/25/2002 | WO2002028439A3 Transferrin-polycation/dna complexes for the systemic treatment of tumour diseases using cytotoxic proteins |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002012461A3 Regulation of human membrane-type serine protease |
| 07/25/2002 | WO2002008448A3 Non-viral linear dna vectors and methods for using the same |
| 07/25/2002 | WO2001097872B1 Bioadhesive compositions and methods of preparation and use |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001092891A3 Regulating lipid levels via the zmax1 or hbm gene |
| 07/25/2002 | WO2001088160A3 Vectors for dna delivery |
| 07/25/2002 | WO2001085940A3 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 07/25/2002 | WO2001074346A3 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001064904A3 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 07/25/2002 | WO2001057208A3 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 07/25/2002 | WO2001042297A9 Clasp-3 transmembrane protein |
| 07/25/2002 | WO2001032204A3 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 07/25/2002 | WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 07/25/2002 | WO2001030812A9 Activation of hcv-specific t cells |
| 07/25/2002 | WO2001015676A3 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 07/25/2002 | WO2001011026A9 Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) |
| 07/25/2002 | WO2001011011A9 Multipotent adult stem cells and methods for isolation |
| 07/25/2002 | WO2001002559A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/25/2002 | WO2001000879A9 Novel kinases and uses thereof |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000791A9 Stress-responsive induction of a therapeutic agent and methods of use |
| 07/25/2002 | US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect |
| 07/25/2002 | US20020100066 Negative strand rna viral vector having autonomous replication capability |
| 07/25/2002 | US20020099190 Nuclelotide sequences coding protein for use in the treatment and prevention of atherosclerosis, osteoporosis and nervous system disorders |
| 07/25/2002 | US20020099188 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/25/2002 | US20020099178 Growth-associated protease inhibitor heavy chain precursor |
| 07/25/2002 | US20020099093 For use in testing systemic carnitine deficiency |
| 07/25/2002 | US20020099040 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 07/25/2002 | US20020099029 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099026 Noninvasive; gene therapy; introducing electromagnetic field response elements into a gene promoter to serve as switches for regulating exogenously introduced genes; and applying electromagnetic field to induce gene expression. |
| 07/25/2002 | US20020099025 Treatment of neurological disorders |
| 07/25/2002 | US20020099024 Including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell. |
| 07/25/2002 | US20020099015 Gene expression control DNA element and associated protein |
| 07/25/2002 | US20020099010 Neurogenic compositions and methods |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020099006 Herpes viruses for immune modulation |
| 07/25/2002 | US20020098583 Composition for use in the treatment of cell cycle defects, autoimmune diseases, aging, cancer, leukemia and psoriasis |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098572 Conditional replication and expression system |
| 07/25/2002 | US20020098549 Mouse EDG1 |
| 07/25/2002 | US20020098545 Nucleotide sequences coding preferential polypeptide for use in diagnosis, detection and treatment of immunological defects |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098530 Tumor suppressor gene |
| 07/25/2002 | US20020098480 Nucleic acid mutation detection in histologic tissue |
| 07/25/2002 | US20020098475 Bovine immunodeficiency virus (BIV) based vectors |
| 07/25/2002 | US20020098359 Method and apparatus for manufacture of magnetizable microparticles |
| 07/25/2002 | US20020098231 Antisense nucleotides; drug delivery; anticancer agents; gene expression inhibition |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098203 Immnunologically active substance embedded in microparticles consisting of starch with amylopectin content greater than 85%; non-crosslinked |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098200 Polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA encoding said proteins |
| 07/25/2002 | US20020098199 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences |
| 07/25/2002 | US20020098170 Herpes simplex virus type 1 ( HSV-1)-derived vector for selectively inhibiting maligant cells and methods for its use to treat cancer and to express desired traits in maligant and non-miligant mammalian cells |
| 07/25/2002 | US20020098168 Useing a recombinant vector to introduce genes encoding a product into a target cell of a mammalian host for infection |
| 07/25/2002 | US20020098166 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 07/25/2002 | US20020098165 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/25/2002 | US20020098162 Decoy which antagonizes the nucleic acid domain to which NF-kappa B is bound; antiischemic, inflammatorie, anticancer agents and treatment of cachexia and autoimmune diseases |
| 07/25/2002 | CA2435443A1 Method of enhancing delivery of a therapeutic nucleic acid |
| 07/25/2002 | CA2435394A1 Modified zinc finger binding proteins |
| 07/25/2002 | CA2435287A1 Nucleic acid delivery formulations |
| 07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | CA2435094A1 Vector for introducing molecules in eukaryotic cells and molecules vectorized by same |
| 07/25/2002 | CA2434387A1 Selectable marker for genetically engineered cells and tissues |
| 07/25/2002 | CA2433419A1 A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |